Lemus David 4
4 · Sorrento Therapeutics, Inc. · Filed Aug 30, 2021
Insider Transaction Report
Form 4
Lemus David
Director
Transactions
- Award
Stock option (right to buy)
2021-08-30+250,000→ 250,000 totalExercise: $8.86Exp: 2031-08-30→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]1/48th of the original number of shares subject to this option shall vest and become exercisable on September 30, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.